Physician profile
Ahan Hunter
NPI 1932633534
$378.90
in general payments reported to CMS, 2019-2025
10 companies · $37.19 in 2025
The $37.19 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $36.70 · 2022: $99.31 · 2023: $172 · 2024: $33.71 · 2025: $37.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $242.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $130.14 | 2023 | Ligasure |
| Myovant Sciences INC. | $63.41 | 2022 | |
| Coopersurgical, INC. | $39.82 | 2023-2024 | Wallach Cryosurgical Equipment, Summit Doppler |
| Avion Pharmaceuticals | $36.31 | 2021-2022 | |
| Intuitive Surgical, INC. | $22.17 | 2023 | Da Vinci Surgical System |
| Therapeuticsmd, INC. | $20.94 | 2021 | |
| Hologic Sales and Service, LLC | $19.63 | 2025 | Fluent Fluid Management System, Novasure |
| Sage Therapeutics, LLC | $17.56 | 2025 | Zurzuvae |
| Pfizer INC. | $15.35 | 2022 | |
| Meditrina | $13.57 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahan Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.